SCHEMBL4295752

SCHEMBL4295752

CC(CCc1nc2c(nc(-c3ccc(Cl)cc3)n2C)c(=O)[nH]1)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PDE9A O76083 2/20 0.38
PDE1C Q14123 1/20 0.38
ALDH1A1 P00352 5/20 0.37
HPGD P15428 4/20 0.37
KDM4E B2RXH2 2/20 0.37
PKM P14618 1/20 0.37
DHFR P00374 2/20 0.37
MAPT P10636 2/20 0.35
PARP1 P09874 1/20 0.35
PDE10A Q9Y233 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 2/20 0.33
GAA P10253 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4288221 0.91 HPGD (0.37) KMT2APDE9APDE1CALDH1A1HPGD
SCHEMBL4296187 0.90 PDE9A (0.48) MEN1KMT2APDE9APDE1CALDH1A1
SCHEMBL4297801 0.90 PDE9A (0.48) MEN1KMT2APDE9APDE1CALDH1A1
SCHEMBL4290696 0.88 ALDH1A1 (0.38) MEN1KMT2APDE9APDE1CALDH1A1
SCHEMBL4292483 0.87 PDE9A (0.36) MEN1KMT2APDE9APDE1CALDH1A1
SCHEMBL4774152 0.85 PARP1 (0.38) PDE9APDE1CALDH1A1HPGDKDM4E
SCHEMBL4769038 0.83 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL4776971 0.82 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL4775804 0.82 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL4290740 0.82 MEN1 (0.42) MEN1KMT2APDE9APDE1CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061470-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES Neurogen Corporation (US) 2009-05-27 EP claimed
WO-2008024433-A2 HALOALKYL-SUBSTITUTED PYRIMIDINONE DERIVATIVES NEUROGEN CORPORATION (US) 2008-02-28 WO claimed